According to Nammex, cultivated turkey tail is more consistent in quality compared to wildcrafted supplies, and creates less pressure on the ecosystem as the mushroom sees rapid growth in demand.
Nammex (Gibson, BC, Canada) has announced in a press release that it has seen an exponential increase in the amount of cultivated turkey tail mushroom harvested by their partner farmers in the third year of its pioneering initiative to cultivate turkey tail. According to Nammex, cultivated turkey tail is more consistent in quality compared to wildcrafted supplies, and creates less pressure on the ecosystem as the mushroom sees rapid growth in demand. Turkey tail mushrooms have been used traditionally in immune support applications, and are currently being utilized more by Western healthcare practitioners, which is generating greater demand as well as raising their market value.
“In 2021, our inaugural year of commercial production of the first and only large-scale cultivation of turkey tail ever attempted, we produced 8,000 kilos of dried mushrooms,” said Skye Chilton, CEO of Nammex, in a press release. “We’re pleased with how well the cultivation program is scaling, producing 12,000 kilos in 2022, and an impressive 30,000 kilos in 2023. We’ve projected 80,000 kilos of dried material for 2024 with an ultimate goal of scaling to 150,000-200,000 kilos annually.”
Nammex states that wildcrafted turkey tail mushrooms have on multiple occasions failed to meet the company’s standards for pesticide and heavy metal levels despite growing in the wild. By contrast, the high yield cultivar grown on wood-based materials have consistently met the high standards set by regulatory agencies.
“We can lessen some of the demand for the wildcrafted Turkey tail, thereby reducing environmental harvesting stress, and at the same time optimize the health benefits with a higher quality mushroom,” said Chilton.
Magnesium L-threonate, Magtein, earns novel food authorization in the European Union
December 19th 2024According to the announcement, the authorization is also exclusive to AIDP and its partner company and licensee, ThreoTech, meaning that they are the only parties that can market magnesium L-threonate in the EU for a period of five years.
Survey finds a lack of enthusiasm about AI technology among food and beverage consumers
December 12th 2024The survey, commissioned by Ingredient Communications and conducted by SurveyGoo, found that 83% of respondent agreed that companies should declare on product labels when a product has been designed or manufactured with the assistance of AI technology.